Rate This Document

Development and Commercialization of Combination Products A Drug-Eluting Stent Case Study TAXUS Express2 - From Development to Approval

• Description: October 2004, by Kathleen M. Miller, Program Manager Drug Delivery, Boston Scientific (4.15 MB)
• Published on: Nov 15, 2023
• Rating Period:

Rate this document Average rating:

()

★

Newest on top Oldest on top

Load more reviews

Rating

Your name

Email (optional)

New code

Please type the code above

Submit

Your rating for this document has already been submitted

Login to be able to write a review

|

()